YourCOPDquestionsanswered byvisitinginternational respiratoryexpert,ProfessorGregKing.
DelveintothelatestCOPDupdateswithRespiratoryPhysicianGregKingas hesharesthelatestrecommendationsondrugtreatmentforexacerbating COPDpatients.
Inthissession,you'lllearnabout:
• InitiatingandsteppingupinhaledtreatmentforCOPD
• TheimportanceofpreventingCOPDexacerbations
• Theimportanceofsingleinhalertripletherapy(SITT)
• TheroleofinhaledcorticosteroidsinCOPD
• TheroleofnewlyfundedTrelegyElliptainCOPDtreatment
Date: 25th June 2024
Presentation & DinnerTime:
6pm: Arrival and refreshments
6:30pm: Presentation starts 7:15pm: Q&A
7:30pm: Dinner to follow
Venue: Trinity Wharf
Address: 51 Dive Crescent, Tauranga
RSVP toyour local GSK representative: Nathan Douglas nathan.j.douglas@gsk.com 021 824 513
Professor Greg King
Dr.GregKingisarespiratoryphysicianattheRoyal NorthShoreHospital,TheWoolcockInstituteof MedicalResearchandNorthernClinicalSchool, UniversityofSydney. Hehasaresearchandclinical practiceinterestandfocusinasthma,COPDand bronchiolitisobliteransinhaematopoieticstem celltransplant.Hisresearchinvolvescomplexlung functionandimagingtomeasurephysiologythatis relevanttodiseasemechanismsandcharacterisation, tobetterunderstandandmanage(andmaybeone day-cure) airwaysdiseasesintheclinic.
Please RSVP by: 19th June 2024 (along with any dietary requirements)
This eventisorganisedandfullyfundedbyGSK andcontainspromotionalinformation.
References: 1.TrelegyElliptaDataSheet, GSKNew Zealand,availableatwww.medsafe.govt.nz. [AccessedMay2024].2.PHARMACPharmaceuticalScheduleApril2024.Availableat www.pharmac.govt.nz/pharmaceutical-schedule.[AccessedMay2024].TAPSDA2356YH-PM-NZ-FVU-LBND-240006DateofApproval:052024DateofExpiry:042025
